SEC13 is a highly conserved gene encoding a core structural component of the COPII (coat protein complex II) vesicular transport machinery, which governs the critical anterograde trafficking of newly synthesized proteins from the endoplasmic reticulum (ER) to the Golgi apparatus. The SEC13 protein, characterized by the presence of WD40 repeat domains that serve as versatile protein-protein interaction modules, stabilizes the assembly of the COPII coat alongside other essential subunits such as SEC31 and the SEC23/SEC24 heterodimer, thereby facilitating the budding of transport vesicles from the ER membrane. Proper function of this complex is vital for maintaining cellular homeostasis; consequently, loss-of-function mutations in SEC13 can lead to the accumulation of misfolded or untransported proteins within the ER, triggering the unfolded protein response (UPR) and ER stress. Such defects have been implicated in the pathogenesis of congenital disorders of glycosylation (CDG) and certain hepatic diseases, while also contributing to neurodegenerative conditions like Alzheimer’s disease through the failure to clear toxic protein aggregates. Conversely, dysregulated expression of SEC13, whether through overexpression that may cause ER membrane depletion and Golgi dysfunction or through downregulation that impairs vesicle formation and secretion, can compromise cellular viability and potentially induce apoptosis. Beyond its canonical role in the secretory pathway, SEC13 is also involved in vascular biology, where its aberrant expression has been linked to tumor angiogenesis, highlighting its multifaceted role in maintaining membrane dynamics and its significance in both physiological and pathological contexts.
Subcellular localization of SEC13 (and its protein):
Gene Ontology (GO) terms for SEC13:
| Interacting Gene | Interaction | Source/Score |
| Name |
|---|
| 3013 RNA transport [PATH:hsa03013] |
| 4141 Protein processing in endoplasmic reticulum [PATH:hsa04141] |
| Name |
|---|
| Adaptive Immune System |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| Asparagine N-linked glycosylation |
| Cell Cycle |
| Cell Cycle, Mitotic |
| Class I MHC mediated antigen processing & presentation |
| COPII (Coat Protein 2) Mediated Vesicle Transport |
| ER to Golgi Transport |
| Immune System |
| M Phase |
| Membrane Trafficking |
| Metabolism of proteins |
| MHC class II antigen presentation |
| Mitotic Anaphase |
| Mitotic Metaphase and Anaphase |
| Mitotic Prometaphase |
| Post-translational protein modification |
| Resolution of Sister Chromatid Cohesion |
| RHO GTPase Effectors |
| RHO GTPases Activate Formins |
| Separation of Sister Chromatids |
| Signaling by Rho GTPases |
| Transport to the Golgi and subsequent modification |
| Vesicle-mediated transport |
| Disease | Score | NofPmids | NofSnps | Source |
| Von Hippel-Lindau Syndrome | 0.000271442 | 1 | 0 | BeFree |
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]